Article
Modified adenoviruses for cancer gene therapy
15 Mar 2004
Abstract excerpt
Adenoviral gene therapy is an exciting novel approach for treating cancers resistant to currently available therapies. However, currently there is little evidence supporting significant clinical benefits with replication-incompetent adenoviruses. Recent data suggest that expression of the primary receptor, the coxsackie-adenovirus receptor (CAR), may be highly variable on tumor cells, resulting in resistance to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
